BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 9, 2015
View Archived Issues
Urine-based prostate cancer diagnostic may help avoid unnecessary biopsies
Read More
Ferritin and IL-8 associated with clear cell renal carcinoma outcome
Read More
Bacteriolytic therapy feasible in advanced sarcoma patients
Read More
Malin plans to float on the ESM of Irish stock exchange to fund acquisitions and investments
Read More
FDA fast tracks AXS-02 for pain associated with complex regional pain syndrome
Read More
EMD Serono presents data from phase I study of MSC-2363318A
Read More
Ironwood Pharmaceuticals begins phase I study of IW-1973
Read More
TG Therapeutics and Checkpoint Therapeutics to develop immuno-oncology targeted antibodies
Read More
AOP Orphan completes enrollment in phase III trial of ropeginterferon alfa 2b
Read More
Phase III trial of VSV-EBOV for Ebola launching in Guinea
Read More
Eisai and Merck & Co. collaborate to study combination therapies in cancer
Read More
Baxter acquires SuppreMol
Read More
Tekmira completes merger with OnCore to create hepatitis B solutions company
Read More
FDA approves biosimilar product Zarxio
Read More
MAASTRO discloses dual action carbonic anhydrase inhibitors
Read More
Medshine Discovery patents DGAT-1 inhibitors
Read More
BioMmune reports in vivo progress in restoring immune recognition in cancer
Read More
U.S. scientists present novel and specific CYP26A1 inhibitors
Read More
Takeda reports development of lysophosphatidic acid receptor antagonists
Read More
Studies advance darunavir/cobicistat/emtricitabine/tenofovir alafenamide single tablet formulation
Read More
Merck & Co. describes new PAR-1 antagonists
Read More
FDA places hold on enrollment in ENDO trial of EndoBarrier
Read More
FDA approves Cresemba for invasive aspergillosis and invasive mucormycosis
Read More
Meiji Seika Pharma initiates phase III Japanese study of ziprasidone
Read More
Biogen Idec Japan launches long-acting agent for hemophilia A in Japan
Read More
